Skip to content
MarketScale
Creator HubsCarevive
Carevive logo

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Carevive is an oncology health technology company that gives care teams a remote patient monitoring platform to track symptoms, collect patient-reported outcomes, and manage cancer patients between clinic visits. The system is designed to surface actionable data for clinicians while reducing the burden on patients managing complex treatment regimens. On MarketScale, Carevive publishes content for oncology administrators, clinicians, and health systems evaluating remote care management tools.

51 episodes
Channel Brief·Carevive · 51 episodes
Updated Jan 9, 2023

Patient-reported data reshapes oncology care and payment models.

Carevive argues that real-time patient experience data, collected at the point of care, drives better clinical decisions and revenue outcomes. The channel proves this through longitudinal datasets, clinical examples, and the shift from OCM to EOM.

Carevive's core argument is that oncology care improves when patient-reported outcomes (PROs) are captured continuously during treatment and integrated directly into clinician workflows. The channel demonstrates this through real-world examples: a 76-year-old NSCLC patient with brain metastases whose symptom burden and treatment bother are tracked over time, revealing when interventions are needed; and a metastatic breast cancer patient whose alert history and severity data inform personalized care decisions in real-time.

Drawn from Patient Grand Rounds Example and 1 more

Big data provides only sequential snapshots without continuous assessment of patient experience, which can only originate from patients themselves.

Improving the Patient Experience in Cancer (Episode 5)

By the numbers

over 600,000

unique data points from 19,000 surveys across 26 cancer types

1,700+

patients represented in Carevive registry

26

cancer types covered in longitudinal dataset

19,000

completed surveys over two years

What the channel argues

DataCarevive's registry spans 1,700+ patients across 26 cancer types with 19,000 completed surveys.
InsightEOM replaces OCM starting July 1, 2023, supporting care for seven common cancer types with focus on health equity.
InsightPRO integration into clinical workflow reduces hospitalizations and emergency room visits, per published studies.
InsightAlert triggers for moderate-to-severe symptoms enable care teams to respond promptly and document interventions.
InsightCarevive's platform captures real-time patient data at point of care with seamless clinician workflow integration.
InsightNSCLC patient cohort top concerns center on cost of care and making right treatment decisions.

What you'll learn

How patient-reported outcomes collected continuously during treatment reveal symptom patterns and treatment burden that sequential clinical snapshots miss.
Why the shift from OCM to EOM opens revenue and care quality opportunities for oncology centers transitioning from Fee-for-Service models.
How real-world patient data from diverse clinical settings complements and extends insights beyond traditional clinical trial populations.
What makes longitudinal patient engagement data actionable: alert systems, temporal summaries, and seamless integration into existing care team workflows.
How early-stage versus advanced disease patients experience treatment differently, requiring tailored monitoring and intervention strategies.

What to do about it

Audit current PRO collection processes for workflow friction and implement system-wide alert triggers for moderate-to-severe symptoms.
Analyze cost-of-care and treatment decision concerns in your patient population using longitudinal survey data to inform patient education and decision support.
Pilot real-world data collection across early-stage and metastatic populations separately to understand disease-stage-specific tolerability and function impacts on treatment planning.

Who and what shows up

Dr. Aaron Galaznik

Chief Scientific Officer, Carevive

Hosted webinar on smart data insights in lung cancer and highlighted alert system design for moderate-to-severe symptom notification to care teams.

John Elliot

VP of Sales, Carevive

Discussed revenue-enhancing opportunities in the OCM-to-EOM transition and expectations for cancer care under the new model.

Dr. Ethan Basch

Expert in digital remote monitoring and ePROs

Led webinar discussion on implementing electronic patient-reported outcomes and optimizing data collection and utilization across cancer programs.

Questions this channel answers

Q

What is the Enhanced Oncology Model (EOM) and when does it take effect?

EOM succeeds OCM on July 1, 2023, supporting clinicians caring for patients with seven common cancer types and focusing on health equity and accountable, affordable care.

The New Oncology Model Created to Improve Cancer Care
Q

How does Carevive's data differ from traditional big data in healthcare?

Carevive captures continuous, real-time patient-reported experience throughout treatment, whereas traditional big data provides only discrete sequential snapshots without capturing the patient's ongoing experience.

Improving the Patient Experience in Cancer
Q

What makes Carevive's platform unique in cancer care delivery?

End-to-end integration of patient questionnaires, real-time alerts for severe symptoms, and seamless feedback loops into care team workflows enable actionable PRO data during active treatment phases.

NSCLC Webinar: Why is Carevive Unique?
Q

How does patient engagement and compliance manifest in Carevive data?

The platform demonstrates high patient compliance with survey follow-ups during the critical first three months of treatment, when care teams must closely monitor treatment experiences and intervene on adherence challenges.

Patient Engagement and Compliance
Q

How can real-world data inform clinical trial design?

Carevive's contemporary data from standard-of-care populations supports FDA-relevant PRO measure selection, unlike historical trial data that becomes outdated as oncology standards rapidly evolve.

CV/COS Webinar: Applications and Future Directions
Topics:Patient-reported outcomes (PROs) in oncologyOncology Care Model (OCM) to Enhanced Oncology Model (EOM) transitionReal-world longitudinal data registriesRemote symptom monitoring and alert systemsClinical trial design informed by real-world data
Themes:Patient voice as clinical dataReal-world evidence beyond trial populationsActionable alerts over passive reporting

Industry context

The oncology market is expanding rapidly, with pharmaceutical and diagnostics segments each projected to grow at double-digit rates through 2034, creating demand for real-world clinical insights and patient-generated data to inform treatment decisions.

Want a show like this for your brand?

MarketScale produces and distributes branded shows like Carevive for B2B companies.

Build your show →